Sitagliptin CAS 486460-32-6 Purity >99,0% (HPLC) API Factory High Purity
Pasokan Sitagliptin Phosphate Monohydrate Related Intermediate:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Asam Trifluorophenylacetic CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Asam Butyric CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Intermediate CAS 486460-21-3
Ngaran Kimia | Sitagliptin |
sinonim | (3R)-3-Amino-1-[3-(trifluorométil)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pirazin-7-yl]-4- (2,4,5-trifluorophenyl)butan-1-hiji |
Nomer CAS | 486460-32-6 |
Status saham | Dina Stok, Skala Produksi Nepi ka Ton |
Formula Molekul | C16H15F6N5O |
Beurat Molekul | 407.31 |
Titik lebur | 114,0 ~ 115,0 ℃ |
merek | Kimia Ruifu |
Barang | spésifikasi |
Penampilan | Bodas ka Pareum-Bodas Bubuk Kristal |
Idéntifikasi ku HPLC | Waktu Panyimpenan Sampel Saluyu sareng Standar Rujukan |
Leungitna dina Drying | <1,0% |
Résidu on Ignition | <0,20% |
Zat Patali | |
Sakur Najis Tunggal | <0,50% |
Total Kotoran | <1,0% |
Kasucian | > 99,0% (HPLC) |
Enantiomeric Purity | <0,50% |
Logam beurat | <20ppm |
Standar tés | Standar Perusahaan |
Pamakéan | API;Diabetes Mellitus Tipe II |
Bungkusan: Botol, kantong Aluminium foil, 25kg / Karton Drum, atawa nurutkeun sarat customer urang.
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap.
Sitagliptin (CAS: 486460-32-6), salaku jinis ubar antidiabetik énggal, Sitagliptin Phosphate ngagaduhan kaunggulan gumantungna glukosa, pangaruh hypoglycemic sedeng, ningkat sékrési tanpa hipoglisemia, ngaleungitkeun rasa lapar sacara efektif, sareng henteu ngagaduhan efek samping sapertos seueul, utah, busung lapar jeung ngaronjat beurat awak.Sitagliptin fosfat salaku pangobatan ubar tunggal dina pasien kalayan diabetes tipe II tiasa sacara signifikan ngirangan tingkat hemoglobin glikosilasi (HbA1c).Éta mangrupikeun inhibitor dipeptidyl peptidase-4 (DPP-4), anu tiasa ningkatkeun kamampuan awak manusa pikeun ngirangan tingkat glukosa darah tinggi.Sitagliptin dikembangkeun ku Merck & Co. sareng disatujuan pikeun panggunaan médis di Amérika Serikat dina 2006.